1,634
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

The potential role of methyltransferase-like 5 in deficient mismatch repair of uterine corpus endometrial carcinoma

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 5525-5536 | Received 21 Oct 2021, Accepted 26 Jan 2022, Published online: 15 Feb 2022

References

  • Wang P, Zeng Z, Shen X, et al. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma. DNA Cell Biol. 2020;39(4):615–630.
  • Akhtar M, Al Hyassat S, Elaiwy O, et al. Classification of Endometrial Carcinoma: new Perspectives Beyond Morphology. Adv Anat Pathol. 2019;26(6):421–427.
  • Todo Y, Kato H, Kaneuchi M, et al. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet. 2010;375(9721):1165–1172.
  • Stelloo E, Nout RA, Osse EM, et al. Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts. Clin Cancer Res. 2016;22(16):4215–4224.
  • Leon-Castillo A, Britton H, McConechy MK, et al. Interpretation of somatic POLE mutations in endometrial carcinoma. J Pathol. 2020;250(3):323–335.
  • Eto T, Zhao Y, Maruyama A, et al. Modal variety of microsatellite instability in human endometrial carcinomas. J Cancer Res Clin Oncol. 2016;142(2):353–363.
  • Jones NL, Xiu J, Rocconi RP, et al. Immune checkpoint expression, microsatellite instability, and mutational burden: identifying immune biomarker phenotypes in uterine cancer. Gynecol Oncol. 2020;156(2):393–399.
  • Willvonseder B, Stogbauer F, Steiger K, et al. The immunologic tumor microenvironment in endometrioid endometrial cancer in the morphomolecular context: mutual correlations and prognostic impact depending on molecular alterations. Cancer Immunol Immunother. 2021;70(6):1679–1689.
  • van Tran N, Ernst FGM, Hawley BR, et al. The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112. Nucleic Acids Res. 2019;47(15):7719–7733.
  • Ignatova VV, Stolz P, Kaiser S, et al. The rRNA m(6)A methyltransferase METTL5 is involved in pluripotency and developmental programs. Genes Dev. 2020;34(9–10):715–729.
  • Richard EM, Polla DL, Assir MZ, et al. Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly. Am J Hum Genet. 2019;105(4):869–878.
  • Rong B, Zhang Q, Wan J, et al. Ribosome 18S m(6)A Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth. Cell Rep. 2020;33(12):108544.
  • Sun S, Fei K, Zhang G, et al. Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung Adenocarcinomas. Front Genet. 2020;11:617174.
  • Stadler ZK, Maio A, and Chakravarty D, et al. Therapeutic Implications of Germline Testing in Patients With Advanced Cancers. J Clin Oncol. 2021;39(24):2698-2709.
  • Fernando SR, Lee CL, Wong BP, et al. Expression of membrane protein disulphide isomerase A1 (PDIA1) disrupt a reducing microenvironment in endometrial epithelium for embryo implantation. Exp Cell Res. 2021;405(2):112665.
  • Li GZ, Deng JF, Qi YZ, et al. COLEC12 regulates apoptosis of osteosarcoma through Toll-like receptor 4-activated inflammation. J Clin Lab Anal. 2020;34(11):e23469.
  • Liu D, Gunther K, Enriquez LA, et al. ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target. Sci Rep. 2020;10(1):13906.
  • Ma M, Chai K, Deng R. Study of the correlation between the noncanonical pathway of pyroptosis and idiopathic inflammatory myopathy. Int Immunopharmacol. 2021;98:107810.
  • Jiang L, Niu W, Zheng Q, et al. Identification of an Autoantibody Against ErbB-3-Binding Protein-1 in the Sera of Patients With Chronic Hepatitis B Virus Infection. Front Immunol. 2021;12:640335.
  • Chu Q, Wang S, Jiang L, et al. Patulin induces pyroptosis through the autophagic-inflammasomal pathway in liver. Food Chem Toxicol. 2021;147:111867.
  • Liu Q, Chen L, Liang X, et al. Exercise attenuates angiotensin-induced muscle atrophy by targeting PPARgamma/miR-29b. J Sport Health Sci. 2021; DOI:10.1016/j.jshs.2021.06.002.
  • Wang Z, Xu J, Wang Y, et al. Total saponins from Tupistra chinensis baker inhibits growth of human gastric cancer cells in vitro and in vivo. J Ethnopharmacol. 2021;278:114323.
  • Hussein YR, Soslow RA. Molecular insights into the classification of high-grade endometrial carcinoma. Pathology. 2018;50(2):151–161.
  • Lu N, Liu J, Ji C, et al. MiRNA based tumor mutation burden diagnostic and prognostic prediction models for endometrial cancer. Bioengineered. 2021;12(1):3603–3620.
  • Dou Y, Kawaler EA, Cui Zhou D, et al. Proteogenomic Characterization of Endometrial Carcinoma. Cell. 2020;180(4):729–48 e26.
  • Baretti M, Le DT. DNA mismatch repair in cancer. Pharmacol Ther. 2018;189:45–62.
  • Liu J, Eckert MA, Harada BT, et al. m(6)A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol. 2018;20(9):1074–1083.
  • Li Q, Wang C, Dong W, et al. WTAP facilitates progression of endometrial cancer via CAV-1/NF-kappaB axis. Cell Biol Int. 2021;45(6):1269–1277.
  • Zhang Y, Yang Y. Effects of m6A RNA methylation regulators on endometrial cancer. J Clin Lab Anal. 2021;35(9):e23942.
  • Zou Z, Zhou S, Liang G, et al. The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators. Mol Omics. 2021;17(3):438–453.
  • Xu X, Lai Y, Hua ZC. Apoptosis and apoptotic body: disease message and therapeutic target potentials. Biosci Rep. 2019;39(1). DOI:10.1042/BSR20180992